Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 5
1970 3
1971 2
1972 1
1973 5
1974 6
1975 7
1976 4
1977 5
1978 14
1979 9
1980 7
1981 6
1982 2
1983 10
1984 5
1985 3
1986 6
1987 5
1988 10
1989 4
1990 12
1991 13
1992 13
1993 6
1994 12
1995 11
1996 14
1997 18
1998 22
1999 22
2000 36
2001 32
2002 49
2003 57
2004 63
2005 96
2006 104
2007 121
2008 133
2009 145
2010 180
2011 226
2012 226
2013 228
2014 239
2015 238
2016 231
2017 251
2018 222
2019 238
2020 260
2021 296
2022 245
2023 288
2024 62

Text availability

Article attribute

Article type

Publication date

Search Results

4,026 results

Results by year

Filters applied: . Clear all
Page 1
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.
Oh DY, Lee KH, Lee DW, Yoon J, Kim TY, Bang JH, Nam AR, Oh KS, Kim JM, Lee Y, Guthrie V, McCoon P, Li W, Wu S, Zhang Q, Rebelatto MC, Kim JW. Oh DY, et al. Among authors: oh ks. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):522-532. doi: 10.1016/S2468-1253(22)00043-7. Epub 2022 Mar 9. Lancet Gastroenterol Hepatol. 2022. PMID: 35278356 Clinical Trial.
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
Tsien CI, Pugh SL, Dicker AP, Raizer JJ, Matuszak MM, Lallana EC, Huang J, Algan O, Deb N, Portelance L, Villano JL, Hamm JT, Oh KS, Ali AN, Kim MM, Lindhorst SM, Mehta MP. Tsien CI, et al. Among authors: oh ks. J Clin Oncol. 2023 Feb 20;41(6):1285-1295. doi: 10.1200/JCO.22.00164. Epub 2022 Oct 19. J Clin Oncol. 2023. PMID: 36260832 Free PMC article. Clinical Trial.
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. Among authors: oh kh. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Clinical Trial.
The Link between Gut Microbiota and Hepatic Encephalopathy.
Won SM, Oh KK, Gupta H, Ganesan R, Sharma SP, Jeong JJ, Yoon SJ, Jeong MK, Min BH, Hyun JY, Park HJ, Eom JA, Lee SB, Cha MG, Kwon GH, Choi MR, Kim DJ, Suk KT. Won SM, et al. Among authors: oh kk. Int J Mol Sci. 2022 Aug 12;23(16):8999. doi: 10.3390/ijms23168999. Int J Mol Sci. 2022. PMID: 36012266 Free PMC article. Review.
The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism.
Oh M, Jang SY, Lee JY, Kim JW, Jung Y, Kim J, Seo J, Han TS, Jang E, Son HY, Kim D, Kim MW, Park JS, Song KH, Oh KJ, Kim WK, Bae KH, Huh YM, Kim SH, Kim D, Han BS, Lee SC, Hwang GS, Lee EW. Oh M, et al. Among authors: oh kj. Nat Commun. 2023 Sep 15;14(1):5728. doi: 10.1038/s41467-023-41462-9. Nat Commun. 2023. PMID: 37714840 Free PMC article.
Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
Nam MH, Ko HY, Kim D, Lee S, Park YM, Hyeon SJ, Won W, Chung JI, Kim SY, Jo HH, Oh KT, Han YE, Lee GH, Ju YH, Lee H, Kim H, Heo J, Bhalla M, Kim KJ, Kwon J, Stein TD, Kong M, Lee H, Lee SE, Oh SJ, Chun JH, Park MA, Park KD, Ryu H, Yun M, Lee CJ. Nam MH, et al. Among authors: oh kt. Brain. 2023 Jul 3;146(7):2957-2974. doi: 10.1093/brain/awad037. Brain. 2023. PMID: 37062541
Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways.
Yoo EJ, Oh KH, Piao H, Kang HJ, Jeong GW, Park H, Lee CJ, Ryu H, Yang SH, Kim MG, Kim DK, Park SH, Lim BJ, Lee SM, Park CY, Choi SY, Lee-Kwon W, Yang J, Kwon HM. Yoo EJ, et al. Among authors: oh kh. Kidney Int. 2023 Jul;104(1):163-180. doi: 10.1016/j.kint.2023.03.030. Epub 2023 Apr 22. Kidney Int. 2023. PMID: 37088425 Free article.
Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS, An TH, Kim H, Jung E, Kim G, Oh SY, Kim JS, Chun HJ, Jung J, Lee EW, Han BS, Han DH, Lee YH, Han TS, Hur K, Lee CH, Kim DS, Kim WK, Park JW, Koo SH, Seong JK, Lee SC, Kim H, Bae KH, Oh KJ. Lee DS, et al. Among authors: oh kj. Diabetologia. 2023 May;66(5):931-954. doi: 10.1007/s00125-023-05878-8. Epub 2023 Feb 10. Diabetologia. 2023. PMID: 36759348 Free PMC article.
4,026 results